Asthma trials recruiting in Oklahoma

All Asthma trials nationally

Cities in Oklahoma

Recruiting trials in Oklahoma

• A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
  NCT07525375 · Phase: Phase 2 · Ages: 4 Years to 11 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
  NCT06664619 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Oklahoma: Oklahoma City, Tulsa
• A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
  NCT07456033 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Oklahoma: Oklahoma City
• A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
  NCT07323654 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Oklahoma: Edmond
• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
  NCT05757102 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
  NCT07359846 · Phase: Phase 3 · Ages: 12 Years to 80 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
  NCT06023589 · Phase: Phase 3 · Ages: 5 Years to 11 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
  NCT06977581 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Oklahoma: Edmond, Oklahoma City, Tulsa
• Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
  NCT06932263 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Oklahoma: Edmond
• Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
  NCT06307665 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Oklahoma: Oklahoma City, Yukon
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
  NCT06750289 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
  NCT02241265 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · Oklahoma: Oklahoma City
• Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
  NCT06137040 · Phase: Early Phase 1 · Ages: 5 Years to 17 Years · Sex: All (male and female) · Oklahoma: Oklahoma City